Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the levels of (a) overweight and (b) obesity among men.

We have introduced regulations on out-of-home calorie labelling for food sold in large businesses, including restaurants, cafes and takeaways, and regulations restricting the placement of less healthy products in key selling locations in store and online. We are also working with industry to make further progress on reformulation and to ensure it is easier for people to make healthier choices.

The weight loss drug Semaglutide (Wegovy) was launched in the United Kingdom on 4 September and will be made available on the National Health Service in line with National Institute for Health and Care Excellence recommendations to ensure cost effective use. A two-year pilot backed by up to £40 million is being developed to explore ways to make these drugs accessible to patients living with obesity outside of hospital settings.